Business Description
Medivolve Inc
NAICS : 541380
SIC : 8681
ISIN : CA21751Q2080
Description
Medivolve Inc is a healthcare technology and services company. It is engaged in finding and developing disruptive technologies, groundbreaking innovations, and partnerships to help combat COVID-19 and transform human health management. The company operated one reportable segment, the COVID Testing facilities across the United States Of America.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | -9.59 | |||||
Debt-to-Equity | -0.1 | |||||
Debt-to-EBITDA | -0.53 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -92.19 | |||||
Beneish M-Score | -41.91 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -74.9 | |||||
3-Year EBITDA Growth Rate | 71.1 | |||||
3-Year FCF Growth Rate | 59.2 | |||||
3-Year Book Growth Rate | 16.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.34 | |||||
9-Day RSI | 49.62 | |||||
14-Day RSI | 49.47 | |||||
6-1 Month Momentum % | -31.03 | |||||
12-1 Month Momentum % | -77.78 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.05 | |||||
Quick Ratio | 0.05 | |||||
Cash Ratio | 0.02 | |||||
Days Sales Outstanding | 3008.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -39.3 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 109.44 | |||||
Operating Margin % | -387.2 | |||||
Net Margin % | -1570.17 | |||||
FCF Margin % | -121.14 | |||||
ROA % | -172.56 | |||||
ROIC % | -70.67 | |||||
ROC (Joel Greenblatt) % | -822.38 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.88 | |||||
EV-to-EBIT | -0.22 | |||||
EV-to-EBITDA | -0.25 | |||||
EV-to-Revenue | 0.84 | |||||
EV-to-FCF | -0.68 | |||||
Earnings Yield (Greenblatt) % | -454.55 | |||||
FCF Yield % | -139.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MEDVF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medivolve Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.686 | ||
EPS (TTM) ($) | -0.387 | ||
Beta | 3.58 | ||
Volatility % | 469.89 | ||
14-Day RSI | 49.47 | ||
14-Day ATR ($) | 0.005876 | ||
20-Day SMA ($) | 0.010022 | ||
12-1 Month Momentum % | -77.78 | ||
52-Week Range ($) | 0.0012 - 0.058 | ||
Shares Outstanding (Mil) | 27.02 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medivolve Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medivolve Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Medivolve Inc Frequently Asked Questions
What is Medivolve Inc(MEDVF)'s stock price today?
The current price of MEDVF is $0.01. The 52 week high of MEDVF is $0.06 and 52 week low is $0.00.
When is next earnings date of Medivolve Inc(MEDVF)?
The next earnings date of Medivolve Inc(MEDVF) is .
Does Medivolve Inc(MEDVF) pay dividends? If so, how much?
Medivolve Inc(MEDVF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |